208 related articles for article (PubMed ID: 36604567)
1. O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma.
Zhou P; Chang WY; Gong DA; Huang LY; Liu R; Liu Y; Xia J; Wang K; Tang N; Huang AL
Oncogene; 2023 Mar; 42(10):725-736. PubMed ID: 36604567
[TBL] [Abstract][Full Text] [Related]
2. O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation.
Feng Z; Yin J; Zhang Z; Chen Z; Huang L; Tang N; Wang K
Oncogene; 2024 Apr; 43(15):1149-1159. PubMed ID: 38396292
[TBL] [Abstract][Full Text] [Related]
3. Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1/sentrin specific peptidase 7.
Ji P; Liang S; Li P; Xie C; Li J; Zhang K; Zheng X; Feng M; Li Q; Jiao H; Chi X; Zhao W; Zhang S; Wang X
Biochem Biophys Res Commun; 2018 Jul; 502(1):30-42. PubMed ID: 29777712
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAcylation of RAB10 promotes hepatocellular carcinoma progression.
Lv Z; Ma G; Zhong Z; Xie X; Li B; Long D
Carcinogenesis; 2023 Dec; 44(10-11):785-794. PubMed ID: 37218374
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAcylation promotes the migratory ability of hepatocellular carcinoma cells via regulating FOXA2 stability and transcriptional activity.
Huang H; Wu Q; Guo X; Huang T; Xie X; Wang L; Liu Y; Shi L; Li W; Zhang J; Liu Y
J Cell Physiol; 2021 Nov; 236(11):7491-7503. PubMed ID: 33843053
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.
Cao B; Duan M; Xing Y; Liu C; Yang F; Li Y; Yang T; Wei Y; Gao Q; Jiang J
J Cell Mol Med; 2019 Apr; 23(4):2384-2398. PubMed ID: 30677218
[TBL] [Abstract][Full Text] [Related]
7. O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression.
Zhu G; Tao T; Zhang D; Liu X; Qiu H; Han L; Xu Z; Xiao Y; Cheng C; Shen A
Glycobiology; 2016 Aug; 26(8):820-833. PubMed ID: 27060025
[TBL] [Abstract][Full Text] [Related]
8. O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N
Yang Y; Yan Y; Yin J; Tang N; Wang K; Huang L; Hu J; Feng Z; Gao Q; Huang A
Signal Transduct Target Ther; 2023 Feb; 8(1):63. PubMed ID: 36765030
[TBL] [Abstract][Full Text] [Related]
9. BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinoma.
Yu Z; Wu X; Zhu J; Yan H; Li Y; Zhang H; Zhong Y; Lin M; Ye G; Li X; Jin J; Li K; Wang J; Zhuang H; Lin T; He J; Lu C; Xu Z; Zhang X; Li H; Jin X
Cell Mol Life Sci; 2024 Feb; 81(1):82. PubMed ID: 38340178
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis.
Liu R; Gou D; Xiang J; Pan X; Gao Q; Zhou P; Liu Y; Hu J; Wang K; Tang N
Oncogene; 2021 Dec; 40(50):6707-6719. PubMed ID: 34650217
[TBL] [Abstract][Full Text] [Related]
11. Speckle-type POZ protein is negatively associated with malignancies and inhibits cell proliferation and migration in liver cancer.
Huang Y; Tan N; Jia D; Jing Y; Wang Q; Li Z; Zhang J; Liu L; Li J; Chen Z; He X
Tumour Biol; 2015 Dec; 36(12):9753-61. PubMed ID: 26156804
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis.
Duan F; Wu H; Jia D; Wu W; Ren S; Wang L; Song S; Guo X; Liu F; Ruan Y; Gu J
J Hepatol; 2018 Jun; 68(6):1191-1202. PubMed ID: 29454068
[TBL] [Abstract][Full Text] [Related]
13. Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF263.
Wang L; Li G; Zhou Z; Ge C; Chen Q; Liu Y; Zhang N; Zhang K; Niu M; Li W; Zhong X; Wu S; Zhang J; Liu Y
Oncogene; 2023 Jul; 42(30):2329-2346. PubMed ID: 37353617
[TBL] [Abstract][Full Text] [Related]
14. High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate.
Zhou P; Chang WY; Gong DA; Xia J; Chen W; Huang LY; Liu R; Liu Y; Chen C; Wang K; Tang N; Huang AL
Cell Metab; 2023 Nov; 35(11):1961-1975.e6. PubMed ID: 37797623
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.
Zhu Q; Zhou L; Yang Z; Lai M; Xie H; Wu L; Xing C; Zhang F; Zheng S
Med Oncol; 2012 Jun; 29(2):985-93. PubMed ID: 21461968
[TBL] [Abstract][Full Text] [Related]
16. Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation.
Xiang J; Chen C; Liu R; Gou D; Chang L; Deng H; Gao Q; Zhang W; Tuo L; Pan X; Liang L; Xia J; Huang L; Yao K; Wang B; Hu Z; Huang A; Wang K; Tang N
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690219
[TBL] [Abstract][Full Text] [Related]
17. SPOP point mutations regulate substrate preference and affect its function.
Deng Y; Ding W; Ma K; Zhan M; Sun L; Zhou Z; Lu L
Cell Death Dis; 2024 Feb; 15(2):172. PubMed ID: 38409107
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAcylation of SIX1 enhances its stability and promotes Hepatocellular Carcinoma Proliferation.
Chu Y; Jiang M; Wu N; Xu B; Li W; Liu H; Su S; Shi Y; Liu H; Gao X; Fu X; Chen D; Li X; Wang W; Liang J; Nie Y; Fan D
Theranostics; 2020; 10(21):9830-9842. PubMed ID: 32863962
[TBL] [Abstract][Full Text] [Related]
19. The positive feedback between ACSL4 expression and O-GlcNAcylation contributes to the growth and survival of hepatocellular carcinoma.
Wang J; Wang Z; Yuan J; Wang J; Shen X
Aging (Albany NY); 2020 May; 12(9):7786-7800. PubMed ID: 32357142
[TBL] [Abstract][Full Text] [Related]
20. Hyper-O-GlcNAcylation of YB-1 affects Ser102 phosphorylation and promotes cell proliferation in hepatocellular carcinoma.
Liu Q; Tao T; Liu F; Ni R; Lu C; Shen A
Exp Cell Res; 2016 Dec; 349(2):230-238. PubMed ID: 27751836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
